| Product Code: ETC5311269 | Publication Date: Nov 2023 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Ireland`s import of pulmonary/respiratory drug delivery products saw a significant increase with top exporters being Germany, UK, USA, Canada, and Areas, nes. The market concentration measured by HHI shifted from moderate to high, indicating a more consolidated market landscape. The impressive CAGR of 23.25% from 2020 to 2024 highlights the growing demand for these products in Ireland. Moreover, the remarkable growth rate of 68.68% from 2023 to 2024 underscores the accelerating pace of import activities in this sector. This data suggests a thriving market for pulmonary/respiratory drug delivery imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Ireland Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2022 & 2032F |
3.6 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2022 & 2032F |
3.7 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.8 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Ireland Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Ireland |
4.2.2 Growing awareness about pulmonary drug delivery technologies |
4.2.3 Advancements in drug delivery devices for respiratory treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pulmonary drug delivery devices |
4.3.2 High cost associated with development and manufacturing of advanced respiratory drug delivery systems |
5 Ireland Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Ireland Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2022 - 2032F |
6.2 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2022 - 2032F |
6.2.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2022 - 2032F |
6.3 Ireland Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2022 - 2032F |
6.3.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2022 - 2032F |
6.3.4 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2022 - 2032F |
6.4 Ireland Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2022 - 2032F |
6.4.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2022 - 2032F |
7 Ireland Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Ireland Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Number of clinical trials involving pulmonary drug delivery technologies in Ireland |
8.2 Adoption rate of new respiratory drug delivery devices in healthcare facilities |
8.3 Investment in research and development of innovative pulmonary drug delivery solutions |
8.4 Patient satisfaction and compliance rates with pulmonary drug delivery treatments |
8.5 Number of partnerships and collaborations in the Ireland pulmonary drug delivery market |
9 Ireland Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2022 & 2032F |
9.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2022 & 2032F |
9.3 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.4 Ireland Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Ireland Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Ireland Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2025 |
10.2 Ireland Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here